Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo

Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo

Background: Statin has been widely used to treat hyperlipidemia because of its high potency in decreasing cholesterol levels. The present study aimed to examine the lipid-lowering effect of rosuvastatin and the composition, diversity and species abundance of gut microbiome in association with rosuva...

Full description

Bibliographic Details
Main Authors: Yinhui Liu, Xiaobo Song, Huimin Zhou, Xue Zhou, Yunlong Xia, Xin Dong, Wei Zhong, Shaoying Tang, Lili Wang, Shu Wen, Jing Xiao, Li Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Microbiology
Subjects:
gut microbiome
16S rRNA sequencing
rosuvastatin
hyperlipidemia
hypolipidemic effect
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2018.00530/full

Internet

http://journal.frontiersin.org/article/10.3389/fmicb.2018.00530/full

Similar Items